Neurogeneration (formerly Siragen) is developing innovative therapeutics to better the quality of lives of patients suffering from aging and neurodegenerative disorders such as Alzheimer’s disease. Our structure-based small molecule drug discovery program target key signaling mechanisms crucial for the initial manifestation of disease.
Area of focus: Therapeutics
Commencement Date: August 1, 2016
Location: JLABS @ San Diego